Acres Commercial Realty Corp (ACR)
Official siteREAL ESTATE • REIT - MORTGAGE • NYSE
Market Cap: $119.06M
Last updated: Nov 17, 2026 at 11:03 AM ET
Acres Commercial Realty Corp (ACR) Stock Forecast
Analysts expect Acres Commercial Realty (ACR) to earn -$0.22 per share in the fiscal year ending Dec 31, 2026, on revenue of $89.00M. Of 3 analysts, 1 rates the stock Buy or Strong Buy, 2 Hold and 0 Sell or Strong Sell, for a consensus of Buy. For the fiscal year ending Dec 31, 2027, the EPS consensus is $1.23.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 3 ratings average 2.33, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 33% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 1 | 33.3% |
| Buy | 0 | 0.0% |
| Hold | 2 | 66.7% |
| Sell | 0 | 0.0% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Buy
- Total analysts
- 3
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus turns from a loss to a profit and revenue estimates fall 3.3%.
- Fiscal year ending Dec 31, 2026
- -$0.22
- EPS consensus, revenue $89.00M
- Fiscal year ending Dec 31, 2027
- $1.23
- EPS consensus, revenue $86.05M
- Next report
- Mar 2, 2027
- Estimated
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | -$0.22 | -$0.22 to -$0.22 | 1 | $89.00M | $89.00M to $89.00M | 1 |
| Dec 31, 2027 | $1.23 | $0.78 to $1.67 | 2 | $86.05M | $67.26M to $106.70M | 3 |
Quarterly Estimates
The EPS consensus rises from $0.24 for the quarter ending Dec 31, 2026 to $0.32 for the quarter ending Mar 31, 2027.
EPS range
Revenue range
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $0.24 | $0.18 to $0.32 | 4 | $22.42M | $20.38M to $24.78M | 4 |
| Mar 31, 2027 | $0.32 | $0.17 to $0.47 | 2 | $21.45M | $17.54M to $25.90M | 3 |
Estimate Revisions
No EPS estimate for the 3 periods below was revised in the last 30 days.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 0 | 0 |
| Fiscal year ending Dec 31, 2027 | 0 | 0 |
| Quarter ending Mar 31, 2027 | 0 | 0 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has turned from a profit of $0.24 to a loss.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | -$0.22 | $0.24 | $0.24 | $0.24 | $0.24 | N/A |
| Fiscal year ending Dec 31, 2027 | $1.23 | $1.23 | $1.23 | $1.23 | $1.23 | 0.0% |
| Quarter ending Mar 31, 2027 | $0.32 | $0.32 | $0.32 | $0.32 | $0.32 | 0.0% |
Frequently Asked Questions About ACR
What is the ACR stock forecast?
Consensus analyst estimates put Acres Commercial Realty's EPS at -$0.22 for the fiscal year ending Dec 31, 2026, on revenue of $89.00M. The consensus rating from 3 analysts is Buy.
How do analysts rate ACR stock?
Of 3 analysts covering Acres Commercial Realty, 1 rates it Strong Buy, 0 Buy, 2 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.
What EPS do analysts expect from ACR next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$0.22, with estimates from -$0.22 to -$0.22 from 1 analyst. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $1.23, with estimates from $0.78 to $1.67 from 2 analysts.
What revenue do analysts expect from Acres Commercial Realty next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $89.00M, with estimates from $89.00M to $89.00M. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $86.05M, with estimates from $67.26M to $106.70M.
How many analysts cover ACR?
3 analysts rate Acres Commercial Realty stock, and 1 analyst estimates its EPS for the fiscal year ending Dec 31, 2026.
ACR pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors